» Articles » PMID: 19903065

Role of Prolonged Mitotic Checkpoint Activation in the Formation and Treatment of Cancer

Overview
Journal Future Oncol
Specialty Oncology
Date 2009 Nov 12
PMID 19903065
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Mitotic abnormalities are a common feature of human cancer cells, and recent studies have provided evidence that such abnormalities may play a causative, rather than merely incidental role, in tumorigenesis. One such abnormality is prolonged activation of the mitotic checkpoint, which can be provoked by a number of the gene changes that drive tumor formation. At the same time, antimitotic chemotherapeutics exert their clinical efficacy through the large-scale induction of prolonged mitotic checkpoint activation, indicating that mitotic arrest is influential in both the formation and treatment of human cancer. However, how this influence occurs is not well understood. In this perspective, we will discuss the current evidence in support of the potential mechanisms by which prolonged activation of the mitotic checkpoint affects both tumorigenesis and antimitotic chemotherapy.

Citing Articles

Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition.

Rahman M, Olson I, Mansour M, Carlstrom L, Sutiwisesak R, Saber R Mol Cancer Res. 2022; 20(6):938-948.

PMID: 35191501 PMC: 9196639. DOI: 10.1158/1541-7786.MCR-21-0029.


Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in Mutated Ultra High-Risk Neuroblastoma Cell Lines.

Odborn Jonsson L, Sahi M, Lopez-Lorenzo X, Keller F, Kostopoulou O, Herold N Int J Mol Sci. 2021; 22(7).

PMID: 33915913 PMC: 8036447. DOI: 10.3390/ijms22073664.


The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?.

Luserna di Rora A, Martinelli G, Simonetti G J Hematol Oncol. 2019; 12(1):123.

PMID: 31771633 PMC: 6880427. DOI: 10.1186/s13045-019-0808-4.


Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular Dysfunctions.

Cao D, Zhao J, Nguyan L, Nguyen L, Khanal S, Dang X Front Immunol. 2019; 10:1152.

PMID: 31191531 PMC: 6540964. DOI: 10.3389/fimmu.2019.01152.


The origins and functions of hepatic polyploidy.

Zhang S, Lin Y, Tarlow B, Zhu H Cell Cycle. 2019; 18(12):1302-1315.

PMID: 31096847 PMC: 6592246. DOI: 10.1080/15384101.2019.1618123.


References
1.
Wu G . p53 and chemosensitivity. Nat Med. 1996; 2(3):255-6. DOI: 10.1038/nm0396-255a. View

2.
Strobel T, Swanson L, Korsmeyer S, Cannistra S . BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci U S A. 1996; 93(24):14094-9. PMC: 19500. DOI: 10.1073/pnas.93.24.14094. View

3.
Diaz-Rodriguez E, Sotillo R, Schvartzman J, Benezra R . Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc Natl Acad Sci U S A. 2008; 105(43):16719-24. PMC: 2570608. DOI: 10.1073/pnas.0803504105. View

4.
Seymour J, Juneja S, Campbell L, Ellims P, Estey E, Prince H . Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy. Leukemia. 1999; 13(11):1735-40. DOI: 10.1038/sj.leu.2401552. View

5.
Dissing M, Le Beau M, Pedersen-Bjergaard J . Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?. J Clin Oncol. 1998; 16(5):1890-6. DOI: 10.1200/JCO.1998.16.5.1890. View